The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.
Identifieur interne : 000B58 ( PubMed/Corpus ); précédent : 000B57; suivant : 000B59The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.
Auteurs : Yong Hu ; Wei Li ; Ting Gao ; Yan Cui ; Yanwen Jin ; Ping Li ; Qingjun Ma ; Xuan Liu ; Cheng CaoSource :
- Journal of virology [ 1098-5514 ] ; 2017.
English descriptors
- KwdEn :
- Animals, Cell Line, Humans, Immune Evasion, Immune Tolerance, Interferon Type I (metabolism), Nucleocapsid Proteins (metabolism), Protein Binding, SARS Virus (immunology), SARS Virus (pathogenicity), SARS Virus (physiology), Transcription Factors (metabolism), Tripartite Motif Proteins (metabolism), Ubiquitin-Protein Ligases (metabolism), Ubiquitination, Virus Replication.
- MESH :
- chemical , metabolism : Interferon Type I, Nucleocapsid Proteins, Transcription Factors, Tripartite Motif Proteins, Ubiquitin-Protein Ligases.
- immunology : SARS Virus.
- pathogenicity : SARS Virus.
- physiology : SARS Virus.
- Animals, Cell Line, Humans, Immune Evasion, Immune Tolerance, Protein Binding, Ubiquitination, Virus Replication.
Abstract
Severe acute respiratory syndrome (SARS) is a respiratory disease, caused by a coronavirus (SARS-CoV), that is characterized by atypical pneumonia. The nucleocapsid protein (N protein) of SARS-CoV plays an important role in inhibition of type I interferon (IFN) production via an unknown mechanism. In this study, the SARS-CoV N protein was found to bind to the SPRY domain of the tripartite motif protein 25 (TRIM25) E3 ubiquitin ligase, thereby interfering with the association between TRIM25 and retinoic acid-inducible gene I (RIG-I) and inhibiting TRIM25-mediated RIG-I ubiquitination and activation. Type I IFN production induced by poly I·C or Sendai virus (SeV) was suppressed by the SARS-CoV N protein. SARS-CoV replication was increased by overexpression of the full-length N protein but not N amino acids 1 to 361, which could not interact with TRIM25. These findings provide an insightful interpretation of the SARS-CoV-mediated host innate immune suppression caused by the N protein.IMPORTANCE The SARS-CoV N protein is essential for the viral life cycle and plays a key role in the virus-host interaction. We demonstrated that the interaction between the C terminus of the N protein and the SPRY domain of TRIM25 inhibited TRIM25-mediated RIG-I ubiquitination, which resulted in the inhibition of IFN production. We also found that the Middle East respiratory syndrome CoV (MERS-CoV) N protein interacted with TRIM25 and inhibited RIG-I signaling. The outcomes of these findings indicate the function of the coronavirus N protein in modulating the host's initial innate immune response.
DOI: 10.1128/JVI.02143-16
PubMed: 28148787
Links to Exploration step
pubmed:28148787Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.</title>
<author><name sortKey="Hu, Yong" sort="Hu, Yong" uniqKey="Hu Y" first="Yong" last="Hu">Yong Hu</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Wei" sort="Li, Wei" uniqKey="Li W" first="Wei" last="Li">Wei Li</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gao, Ting" sort="Gao, Ting" uniqKey="Gao T" first="Ting" last="Gao">Ting Gao</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cui, Yan" sort="Cui, Yan" uniqKey="Cui Y" first="Yan" last="Cui">Yan Cui</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jin, Yanwen" sort="Jin, Yanwen" uniqKey="Jin Y" first="Yanwen" last="Jin">Yanwen Jin</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ma, Qingjun" sort="Ma, Qingjun" uniqKey="Ma Q" first="Qingjun" last="Ma">Qingjun Ma</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Xuan" sort="Liu, Xuan" uniqKey="Liu X" first="Xuan" last="Liu">Xuan Liu</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China liux931932@163.com cao_c@sohu.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cao, Cheng" sort="Cao, Cheng" uniqKey="Cao C" first="Cheng" last="Cao">Cheng Cao</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China liux931932@163.com cao_c@sohu.com.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28148787</idno>
<idno type="pmid">28148787</idno>
<idno type="doi">10.1128/JVI.02143-16</idno>
<idno type="wicri:Area/PubMed/Corpus">000B58</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B58</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.</title>
<author><name sortKey="Hu, Yong" sort="Hu, Yong" uniqKey="Hu Y" first="Yong" last="Hu">Yong Hu</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Wei" sort="Li, Wei" uniqKey="Li W" first="Wei" last="Li">Wei Li</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gao, Ting" sort="Gao, Ting" uniqKey="Gao T" first="Ting" last="Gao">Ting Gao</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cui, Yan" sort="Cui, Yan" uniqKey="Cui Y" first="Yan" last="Cui">Yan Cui</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jin, Yanwen" sort="Jin, Yanwen" uniqKey="Jin Y" first="Yanwen" last="Jin">Yanwen Jin</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ma, Qingjun" sort="Ma, Qingjun" uniqKey="Ma Q" first="Qingjun" last="Ma">Qingjun Ma</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Xuan" sort="Liu, Xuan" uniqKey="Liu X" first="Xuan" last="Liu">Xuan Liu</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China liux931932@163.com cao_c@sohu.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cao, Cheng" sort="Cao, Cheng" uniqKey="Cao C" first="Cheng" last="Cao">Cheng Cao</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China liux931932@163.com cao_c@sohu.com.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Cell Line</term>
<term>Humans</term>
<term>Immune Evasion</term>
<term>Immune Tolerance</term>
<term>Interferon Type I (metabolism)</term>
<term>Nucleocapsid Proteins (metabolism)</term>
<term>Protein Binding</term>
<term>SARS Virus (immunology)</term>
<term>SARS Virus (pathogenicity)</term>
<term>SARS Virus (physiology)</term>
<term>Transcription Factors (metabolism)</term>
<term>Tripartite Motif Proteins (metabolism)</term>
<term>Ubiquitin-Protein Ligases (metabolism)</term>
<term>Ubiquitination</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Interferon Type I</term>
<term>Nucleocapsid Proteins</term>
<term>Transcription Factors</term>
<term>Tripartite Motif Proteins</term>
<term>Ubiquitin-Protein Ligases</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Line</term>
<term>Humans</term>
<term>Immune Evasion</term>
<term>Immune Tolerance</term>
<term>Protein Binding</term>
<term>Ubiquitination</term>
<term>Virus Replication</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is a respiratory disease, caused by a coronavirus (SARS-CoV), that is characterized by atypical pneumonia. The nucleocapsid protein (N protein) of SARS-CoV plays an important role in inhibition of type I interferon (IFN) production via an unknown mechanism. In this study, the SARS-CoV N protein was found to bind to the SPRY domain of the tripartite motif protein 25 (TRIM25) E3 ubiquitin ligase, thereby interfering with the association between TRIM25 and retinoic acid-inducible gene I (RIG-I) and inhibiting TRIM25-mediated RIG-I ubiquitination and activation. Type I IFN production induced by poly I·C or Sendai virus (SeV) was suppressed by the SARS-CoV N protein. SARS-CoV replication was increased by overexpression of the full-length N protein but not N amino acids 1 to 361, which could not interact with TRIM25. These findings provide an insightful interpretation of the SARS-CoV-mediated host innate immune suppression caused by the N protein.<b>IMPORTANCE</b>
The SARS-CoV N protein is essential for the viral life cycle and plays a key role in the virus-host interaction. We demonstrated that the interaction between the C terminus of the N protein and the SPRY domain of TRIM25 inhibited TRIM25-mediated RIG-I ubiquitination, which resulted in the inhibition of IFN production. We also found that the Middle East respiratory syndrome CoV (MERS-CoV) N protein interacted with TRIM25 and inhibited RIG-I signaling. The outcomes of these findings indicate the function of the coronavirus N protein in modulating the host's initial innate immune response.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28148787</PMID>
<DateCompleted><Year>2017</Year>
<Month>05</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>91</Volume>
<Issue>8</Issue>
<PubDate><Year>2017</Year>
<Month>04</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">e02143-16</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02143-16</ELocationID>
<Abstract><AbstractText>Severe acute respiratory syndrome (SARS) is a respiratory disease, caused by a coronavirus (SARS-CoV), that is characterized by atypical pneumonia. The nucleocapsid protein (N protein) of SARS-CoV plays an important role in inhibition of type I interferon (IFN) production via an unknown mechanism. In this study, the SARS-CoV N protein was found to bind to the SPRY domain of the tripartite motif protein 25 (TRIM25) E3 ubiquitin ligase, thereby interfering with the association between TRIM25 and retinoic acid-inducible gene I (RIG-I) and inhibiting TRIM25-mediated RIG-I ubiquitination and activation. Type I IFN production induced by poly I·C or Sendai virus (SeV) was suppressed by the SARS-CoV N protein. SARS-CoV replication was increased by overexpression of the full-length N protein but not N amino acids 1 to 361, which could not interact with TRIM25. These findings provide an insightful interpretation of the SARS-CoV-mediated host innate immune suppression caused by the N protein.<b>IMPORTANCE</b>
The SARS-CoV N protein is essential for the viral life cycle and plays a key role in the virus-host interaction. We demonstrated that the interaction between the C terminus of the N protein and the SPRY domain of TRIM25 inhibited TRIM25-mediated RIG-I ubiquitination, which resulted in the inhibition of IFN production. We also found that the Middle East respiratory syndrome CoV (MERS-CoV) N protein interacted with TRIM25 and inhibited RIG-I signaling. The outcomes of these findings indicate the function of the coronavirus N protein in modulating the host's initial innate immune response.</AbstractText>
<CopyrightInformation>Copyright © 2017 American Society for Microbiology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName>
<ForeName>Yong</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gao</LastName>
<ForeName>Ting</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cui</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jin</LastName>
<ForeName>Yanwen</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Ping</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ma</LastName>
<ForeName>Qingjun</ForeName>
<Initials>Q</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Xuan</ForeName>
<Initials>X</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China liux931932@163.com cao_c@sohu.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cao</LastName>
<ForeName>Cheng</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pathogen Biosecurity, Beijing Institute of Biotechnology, Beijing, China liux931932@163.com cao_c@sohu.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>03</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000070584">Tripartite Motif Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C099602">nucleocapsid protein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber>
<NameOfSubstance UI="C522809">RNF135 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber>
<NameOfSubstance UI="C084523">TRIM25 protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber>
<NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057131" MajorTopicYN="Y">Immune Evasion</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007108" MajorTopicYN="Y">Immune Tolerance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000070584" MajorTopicYN="N">Tripartite Motif Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">RIG-I</Keyword>
<Keyword MajorTopicYN="Y">SARS coronavirus</Keyword>
<Keyword MajorTopicYN="Y">TRIM25</Keyword>
<Keyword MajorTopicYN="Y">interferon</Keyword>
<Keyword MajorTopicYN="Y">nucleocapsid</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>11</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>01</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>2</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>5</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28148787</ArticleId>
<ArticleId IdType="pii">JVI.02143-16</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.02143-16</ArticleId>
<ArticleId IdType="pmc">PMC5375661</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nat Rev Microbiol. 2005 Oct;3(10 ):799-808</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16175175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2009 Mar;83(5):2255-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19052082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2015 Dec 22;12 :221</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26689940</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Mar;81(6):2554-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17182678</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Jul;42(7):3196-206</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15243082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2004 Mar;10 (3):290-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14981511</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2002 Sep;2(9):675-87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12209136</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2009 Dec 20;395(2):210-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19853271</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2008 Jun 20;371(1):110-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18406349</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):E3900-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25197083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Signal. 2010 Apr 20;3(118):jc2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20407122</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2015 Mar;89(6):2995-3007</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25520500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods. 2001 Dec;25(4):402-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2006 Nov 10;314(5801):997-1001</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17038589</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2013 Dec;11(12):836-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24217413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013 Apr 29;8(4):e62416</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23658627</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2004 Oct;105(2):121-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15351485</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2010 May 17;7:99</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20478047</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Immunol. 2005 Jan 18;6:2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15655079</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2006 May 4;441(7089):101-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16625202</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Microbiol. 2003 Aug;52(Pt 8):715-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12867568</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Biol. 2012 May 24;10 :44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22626058</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 May 14;317(4):1030-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15094372</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Cell. 2012 Nov;3(11):803-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23143870</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2004 May 25;43(20):6059-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15147189</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2003 Mar 14;278(11):9441-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12524442</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Mol Med. 2015 Aug 28;47:e181</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26315600</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19944-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19036930</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1997 Jul;71(7):5481-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9188621</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2003 Aug 8;278(32):29667-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12777400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2007 Apr 19;446(7138):916-920</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17392790</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2006 Feb 24;124(4):783-801</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16497588</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cells. 2015 Sep;38(9):759-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26299329</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2008 Oct 10;380(1):99-108</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18703211</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biomed Sci. 2003 Nov-Dec;10(6 Pt 2):664-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14631105</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2015 Dec 15;212(12):1904-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26198719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2015 Oct 9;350(6257):217-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26138103</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2016 Jun;14 (6):360-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27174148</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2016 Feb 10;19(2):181-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26867177</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Virol. 2012 Jun;2(3):264-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22572391</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Jan;81(2):548-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17108024</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Nov;87(22):12489-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24027320</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2008 Apr;133(1):101-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17451827</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2009 May 8;5(5):439-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19454348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochemistry. 2006 Oct 3;45(39):11827-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17002283</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2008 Mar 1;372(1):127-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18022664</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2008 Dec;8(12):911-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18989317</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2003 Jan;77(2):1501-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12502864</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2007 May 11;368(4):1075-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17379242</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Biochem Cell Biol. 2006;38(8):1417-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16546436</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2008 Nov;8(11):849-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18836477</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Cell. 2013 Dec;4(12):951-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24318862</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Jun;87(12):6604-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23552422</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Immunol. 2014;32:513-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24555472</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2014 Mar;20:42-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24406736</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Genes. 2011 Feb;42(1):37-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20976535</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 May;87(9):5300-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23449793</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2011 Sep 25;479(7373):423-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21947008</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 May;88(9):4866-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24522921</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2003 Dec 24;290(24):3222-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14693875</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B58 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000B58 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:28148787 |texte= The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28148787" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |